Klotho gene deficiency causes salt-sensitive hypertension via monocyte chemotactic protein-1/CC chemokine receptor 2-mediated inflammation

Journal of the American Society of Nephrology

Volumn 26, Issue 1, 2015, Pages 121-132

  Zhou, Xiaoli ^a,b   Chen, Kai ^b   Lei, Han ^a   Sun, Zhongjie ^a,b  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR2; INCB 3284; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; SODIUM CHLORIDE; SODIUM CHLORIDE COTRANSPORTER; BENZAMIDE DERIVATIVE; BETA GLUCURONIDASE; CCL2 PROTEIN, MOUSE; CCR2 PROTEIN, MOUSE; GLYCINE; KLOTHO PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; THIAZIDE DIURETIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CHEMOTAXIS; CONTROLLED STUDY; GENETIC DISORDER; HETEROZYGOTE; HYPERTENSION; INFLAMMATION; KIDNEY DYSFUNCTION; KIDNEY INJURY; KIDNEY STRUCTURE; KLOTHO GENE; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALT INTAKE; SUPPRESSOR GENE; SYSTOLIC BLOOD PRESSURE; T LYMPHOCYTE; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD PRESSURE; CHEMISTRY; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; KIDNEY; METABOLISM; PATHOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; BENZAMIDES; BLOOD PRESSURE; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GLUCURONIDASE; GLYCINE; HETEROZYGOTE; HYPERTENSION; INFLAMMATION; KIDNEY; MACROPHAGES; MICE; MICE, TRANSGENIC; RECEPTORS, CCR2; SODIUM CHLORIDE; T-LYMPHOCYTES; THIAZIDES;

EID: 84924170646     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013101033     Document Type: Article

References (58)

1. Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E, Iwasaki H, Iida A, Shiraki-Iida T, Nishikawa S, Nagai R, Nabeshima YI: Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390: 45-51, 1997
2. Kurosu H, Yamamoto M, Clark JD, Pastor JV, Nandi A, Gurnani P, McGuinness OP, Chikuda H, Yamaguchi M, Kawaguchi H, Shimomura I, Takayama Y, Herz J, Kahn CR, Rosenblatt KP, Kuro-o M: Suppression of aging in mice by the hormone Klotho. Science 309: 1829-1833, 2005
3. Ong KL, Cheung BM, Man YB, Lau CP, Lam KS: Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension 49: 69-75, 2007
4. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr., Jones DW, Materson BJ, Oparil S, Wright JT Jr., Roccella EJ; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute National High Blood Pressure Education Program Coordinating Committee: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42: 1206-1252, 2003
5. Ishibashi K, Oshima T, Matsuura H, Watanabe M, Ishida M, Ishida T, Ozono R, Kajiyama G, Kanbe M: Effects of age and sex on sodium chloride sensitivity: Association with plasma renin activity. Clin Nephrol 42: 376-380, 1994
6. Osanai T, Kanazawa T, Yokono Y, Uemura T, Okuguchi T, Onodera K: Effect of aging on sensitivity of blood pressure to salt. Nihon Ronen Igakkai Zasshi 30: 30-34, 1993
7. Overlack A, Ruppert M, Kolloch R, Göbel B, Kraft K, Diehl J, Schmitt W, Stumpe KO: Divergent hemodynamic and hormonal responses to varying salt intake in normotensive subjects. Hypertension 22: 331-338, 1993
8. Weinberger MH, Fineberg NS: Sodium and volume sensitivity of blood pressure. Age and pressure change over time. Hypertension 18: 67-71, 1991
9. Weinberger MH, Miller JZ, Luft FC, Grim CE, Fineberg NS: Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension 8: II127-II134, 1986
10. Franco M, Sanchez-Lozada LG, Bautista R, Johnson RJ, Rodriguez-Iturbe B: Pathophysiology of salt-sensitive hypertension: A new scope of an old problem. Blood Purif 26: 45-48, 2008
11. Xiao NM, Zhang YM, Zheng Q, Gu J: Klotho is a serum factor related to human aging. Chin Med J (Engl) 117: 742-747, 2004
12. Rollins BJ: Chemokines. Blood 90: 909-928, 1997
13. Johnson RJ, Schreiner GF: Hypothesis: The role of acquired tubulointerstitial disease in the pathogenesis of salt-dependent hypertension. Kidney Int 52: 1169-1179, 1997
14. Carr MW, Roth SJ, Luther E, Rose SS, Springer TA: Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci U S A 91: 3652-3656, 1994
15. Loetscher P, Seitz M, Clark-Lewis I, Baggiolini M, Moser B: Monocyte chemotactic proteins MCP-1, MCP-2, and MCP-3 are major attractants for human CD4+ and CD8+ T lymphocytes. FASEB J 8: 1055-1060, 1994
16. Deshmane SL, Kremlev S, Amini S, Sawaya BE: Monocyte chemoattractant protein-1 (MCP-1): An overview. J Interferon Cytokine Res 29: 313-326, 2009
17. Xia M, Sui Z: Recent developments in CCR2 antagonists. Expert Opin Ther Pat 19: 295-303, 2009
18. Sallusto F, Lanzavecchia A, Mackay CR: Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today 19: 568-574, 1998
19. Bonecchi R, Bianchi G, Bordignon PP, D'Ambrosio D, Lang R, Borsatti A, Sozzani S, Allavena P, Gray PA, Mantovani A, Sinigaglia F: Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 187: 129-134, 1998
20. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A: Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 187: 875-883, 1998
21. Epstein M: Aging and the kidney. J Am Soc Nephrol 7: 1106-1122, 1996
22. Lee YT, Chiu HC, Su HM, Yang JF, Voon WC, Lin TH, Lai WT, Sheu SH: Lower hemoglobin concentrations and subsequent decline in kidney function in an apparently healthy population aged 60 year and older. Clin Chim Acta 389: 25-30, 2008
23. Hu MC, Kuro-o M, Moe OW: The emerging role of Klotho in clinical nephrology. Nephrol Dial Transplant 27: 2650-2657, 2012
24. Xue CB, Wang A, Meloni D, Zhang K, Kong L, Feng H, Glenn J, Huang T, Zhang Y, Cao G, Anand R, Zheng C, Xia M, Han Q, Robinson DJ, Storace L, Shao L, Li M, Brodmerkel CM, Covington M, Scherle P, Diamond S, Yeleswaram S, Vaddi K, Newton R, Hollis G, Friedman S, Metcalf B: Discovery of INCB3344, a potent, selective and orally bioavailable antagonist of human and murine CCR2. Bioorg Med Chem Lett 20: 7473-7478, 2010
25. Seok SJ, Lee ES, Kim GT, Hyun M, Lee JH, Chen S, Choi R, Kim HM, Lee EY, Chung CH: Blockade of CCL2/CCR2 signalling ameliorates diabetic nephropathy in db/db mice. Nephrol Dial Transplant 28: 1700-1710, 2013
26. Mitchell LA, Hansen RJ, Beaupre AJ, Gustafson DL, Dow SW: Optimized dosing of a CCR2 antagonist for amplification of vaccine immunity. Int Immunopharmacol 15: 357-363, 2013
27. Wang HL, Xu Q, Wang Z, Zhang YH, Si LY, Li XJ, Yang QH, Xiao H: A potential regulatory single nucleotide polymorphism in the promoter of the Klotho gene may be associated with essential hypertension in the Chinese Han population. Clin Chim Acta 411: 386-390, 2010
28. Wang Y, Sun Z: Klotho gene delivery prevents the progression of spontaneous hypertension and renal damage. Hypertension 54: 810-817, 2009
29. Saito Y, Nakamura T, Ohyama Y, Suzuki T, Iida A, Shiraki-Iida T, Kuro-o M, Nabeshima Y, Kurabayashi M, Nagai R: In vivo klotho gene delivery protects against endothelial dysfunction in multiple risk factor syndrome. Biochem Biophys Res Commun 276: 767-772, 2000
30. Maekawa Y, Ishikawa K, Yasuda O, Oguro R, Hanasaki H, Kida I, Takemura Y, Ohishi M, Katsuya T, Rakugi H: Klotho suppresses TNF-alpha-induced expression of adhesion molecules in the endothelium and attenuates NF-kappaB activation. Endocrine 35: 341-346, 2009
31. Zhao Y, Banerjee S, Dey N, LeJeune WS, Sarkar PS, Brobey R, Rosenblatt KP, Tilton RG, Choudhary S: Klotho depletion contributes to increased inflammation in kidney of the db/db mouse model of diabetes via RelA (serine)536 phosphorylation. Diabetes 60: 1907-1916, 2011
32. Zhou X, Sun Z: Mutation of anti-aging gene klotho causes hypertension via upregulation of plasma aldosterone levels. FASEB J 904: 12, 2013
33. Franco M, Martínez F, Quiroz Y, Galicia O, Bautista R, Johnson RJ, Rodríguez-Iturbe B: Renal angiotensin II concentration and interstitial infiltration of immune cells are correlated with blood pressure levels in salt-sensitive hypertension. Am J Physiol Regul Integr Comp Physiol 293: R251-R256, 2007
34. Rodríguez-Iturbe B, Vaziri ND, Herrera-Acosta J, Johnson RJ: Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: All for one and one for all. Am J Physiol Renal Physiol 286: F606-F616, 2004
35. Franco M, Tapia E, Bautista R, Pacheco U, Santamaria J, Quiroz Y, Johnson RJ, Rodriguez-Iturbe B: Impaired pressure natriuresis resulting in salt-sensitive hypertension is caused by tubulointerstitial immune cell infiltration in the kidney. Am J Physiol Renal Physiol 304: F982-F990, 2013
36. De Miguel C, Das S, Lund H, Mattson DL: T lymphocytes mediate hypertension and kidney damage in Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol 298: R1136-R1142, 2010
37. Garg LC, Knepper MA, Burg MB: Mineralocorticoid effects on Na-KATPase in individual nephron segments. Am J Physiol 240: F536-F544, 1981
38. Veríssimo F, Jordan P: WNK kinases, a novel protein kinase subfamily in multi-cellular organisms. Oncogene 20: 5562-5569, 2001
39. Kahle KT, Wilson FH, Lifton RP: Regulation of diverse ion transport pathways by WNK4 kinase: A novel molecular switch. Trends Endocrinol Metab 16: 98-103, 2005
40. Rozansky DJ, Cornwall T, Subramanya AR, Rogers S, Yang YF, David LL, Zhu X, Yang CL, Ellison DH: Aldosterone mediates activation of the thiazide-sensitive Na-Cl cotransporter through an SGK1 and WNK4 signaling pathway. J Clin Invest 119: 2601-2612, 2009
41. Kim GH, Masilamani S, Turner R, Mitchell C, Wade JB, Knepper MA: The thiazide-sensitive Na-Cl cotransporter is an aldosterone-induced protein. Proc Natl Acad Sci U S A 95: 14552-14557, 1998
42. Pearce D, Kleyman TR: Salt, sodium channels, and SGK1. J Clin Invest 117: 592-595, 2007
43. Jin S, Ray RM, Johnson LR: TNF-alpha/cycloheximide-induced apoptosis in intestinal epithelial cells requires Rac1-regulated reactive oxygen species. Am J Physiol Gastrointest Liver Physiol 294: G928-G937, 2008
44. Kim H, Hwang JS, Woo CH, Kim EY, Kim TH, Cho KJ, Kim JH, Seo JM, Lee SS: TNF-alpha-induced up-regulation of intercellular adhesion molecule-1 is regulated by a Rac-ROS-dependent cascade in human airway epithelial cells. Exp Mol Med 40: 167-175, 2008
45. Fujita T: Mineralocorticoid receptors, salt-sensitive hypertension, and metabolic syndrome. Hypertension 55: 813-818, 2010
46. Hatakeyama H, Miyamori I, Fujita T, Takeda Y, Takeda R, Yamamoto H: Vascular aldosterone. Biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells. J Biol Chem 269: 24316-24320, 1994
47. Rocha R, Funder JW: The pathophysiology of aldosterone in the cardiovascular system. Ann N Y Acad Sci 970: 89-100, 2002
48. Blacher J, Amah G, Girerd X, Kheder A, Ben Mais H, London GM, Safar ME: Association between increased plasma levels of aldosterone and decreased systemic arterial compliance in subjects with essential hypertension. Am J Hypertens 10: 1326-1334, 1997
49. Gómez-Sánchez EP, Zhou M, Gomez-Sanchez CE: Mineralocorticoids, salt and high blood pressure. Steroids 61: 184-188, 1996
50. Li L, Galligan JJ, Fink GD, Chen AF: Vasopressin induces vascular superoxide via endothelin-1 in mineralocorticoid hypertension. Hypertension 41: 663-668, 2003
51. Hashimoto J, Imai Y, Minami N, Munakata M, Abe K: Effects of vasopressin V1 and V2 receptor antagonists on the development of salt-induced hypertension in Dahl rats. J Cardiovasc Pharmacol 26: 548-554, 1995
52. Kim YB, Kim YS, Kim WB, Shen FY, Lee SW, Chung HJ, Kim JS, Han HC, Colwell CS, Kim YI: GABAergic excitation of vasopressin neurons: Possible mechanism underlying sodium-dependent hypertension. Circ Res 113: 1296-1307, 2013
53. Wang Y, Kuro-o M, Sun Z: Klotho gene delivery suppresses Nox2 expression and attenuates oxidative stress in rat aortic smooth muscle cells via the cAMP-PKA pathway. Aging Cell 11: 410-417, 2012
54. Feng M, Whitesall S, Zhang Y, Beibel M, D'Alecy L, DiPetrillo K: Validation of volume-pressure recording tail-cuff blood pressure measurements. Am J Hypertens 21: 1288-1291, 2008
55. Whitesall SE, Hoff JB, Vollmer AP, D'Alecy LG: Comparison of simultaneous measurement of mouse systolic arterial blood pressure by radiotelemetry and tail-cuff methods. Am J Physiol Heart Circ Physiol 286: H2408-H2415, 2004
56. Sun Z, Cade R, Zhang Z, Alouidor J, Van H: Angiotensinogen gene knockout delays and attenuates cold-induced hypertension. Hypertension 41: 322-327, 2003
57. Sun Z, Bello-Roufai M, Wang X: RNAi inhibition of mineralocorticoid receptors prevents the development of cold-induced hypertension. Am J Physiol Heart Circ Physiol 294: H1880-H1887, 2008
58. Sun Z, Wang X, Wood CE, Cade JR: Genetic AT1A receptor deficiency attenuates cold-induced hypertension. Am J Physiol Regul Integr Comp Physiol 288: R433-R439, 2005